CoChat

Endoproteolysis of औ-Secretase (औ-Site Amyloid Precursor Protein-cleaving Enzyme) within Its Catalytic Domain

Open access
Huse, Jason T., Byant, Damani, Yang, Yaxiong, Pijak, Donald S., D'Souza, Ian, Lah, James J., Lee, Virginia M.-Y., Doms, Robert W., Cook, David G. · 2003 · Journal of Biological Chemistry
Cited by 42

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Sequential proteolysis of the amyloid precursor protein (APP) by औ- and γ-secretase activities yields the amyloid औ peptide that is widely deposited in the brains of individuals with Alzheimer's disease. The membrane-anchored aspartyl protease औ-siteAPP-cleaving enzyme (BACE) exhibits all of the characteristics of a औ-secretase and has been shown to cleave APP at its औ-site in vitro and in vivo. We found that BACE undergoes cleavage on a surface-exposed α-helix between amino acid residues Leu-228 and Ala-229, generating stable N- and C-terminal fragments that remain covalently associated via a disulfide bond. The efficiency of BACE endoproteolysis was observed to depend heavily on cell and tissue type. In contrast to brain where holoprotein was predominant, BACE was found primarily as endoproteolyzed fragments in pancreas, liver, and muscle. In addition, we observed a marked up-regulation of BACE endoproteolysis in C2 myoblasts upon differentiation into multinucleated myotubes, a well established model system of muscle tissue specification. As in liver, BACE exists as endoproteolyzed fragments in the hepatic cell line, HepG2. We found that HepG2 cells are capable of generating amyloid औ peptide, suggesting that endoproteolyzed BACE retains measurable औ-secretase activity. We also found that BACE endoproteolysis occurs only after export from the endoplasmic reticulum, is enhanced in the trans-Golgi network, and is sensitive to inhibitors of vesicular acidification. The membrane-bound proteases tumor necrosis factor α-converting enzyme and furin were not found to be responsible for this cleavage nor was BACE observed to mediate its own endoproteolysis by an autocatalytic mechanism. Thus, we characterize a specific processing event that may serve to regulate the enzymatic activity of BACE on a post-translational level. Sequential proteolysis of the amyloid precursor protein (APP) by औ- and γ-secretase activities yields the amyloid औ peptide that is widely deposited in the brains of individuals with Alzheimer's disease. The membrane-anchored aspartyl protease औ-siteAPP-cleaving enzyme (BACE) exhibits all of the characteristics of a औ-secretase and has been shown to cleave APP at its औ-site in vitro and in vivo. We found that BACE undergoes cleavage on a surface-exposed α-helix between amino acid residues Leu-228 and Ala-229, generating stable N- and C-terminal fragments that remain covalently associated via a disulfide bond. The efficiency of BACE endoproteolysis was observed to depend heavily on cell and tissue type. In contrast to brain where holoprotein was predominant, BACE was found primarily as endoproteolyzed fragments in pancreas, liver, and muscle. In addition, we observed a marked up-regulation of BACE endoproteolysis in C2 myoblasts upon differentiation into multinucleated myotubes, a well established model system of muscle tissue specification. As in liver, BACE exists as endoproteolyzed fragments in the hepatic cell line, HepG2. We found that HepG2 cells are capable of generating amyloid औ peptide, suggesting that endoproteolyzed BACE retains measurable औ-secretase activity. We also found that BACE endoproteolysis occurs only after export from the endoplasmic reticulum, is enhanced in the trans-Golgi network, and is sensitive to inhibitors of vesicular acidification. The membrane-bound proteases tumor necrosis factor α-converting enzyme and furin were not found to be responsible for this cleavage nor was BACE observed to mediate its own endoproteolysis by an autocatalytic mechanism. Thus, we characterize a specific processing event that may serve to regulate the enzymatic activity of BACE on a post-translational level. Alzheimer's disease amyloid औ amyloid precursor protein औ-site APP-cleaving enzyme BACE C-terminal fragment BACE N-terminal fragment tumor necrosis factor a converting enzyme presenilin 1 presenilin 2 endoplasmic reticulum trans-Golgi network influenza hemagglutinin fetal bovine serum phosphate-buffered saline radioimmunoprecipitation assay baby hamster kidney Dulbecco's modified Eagle's medium Semliki Forest virus monoclonal antibody Alzheimer's disease (AD)1 is characterized pathologically by the florid accumulation of insoluble amyloid औ peptide (Aऔ) in the central nervous system (1Glenner G.G. Wong C.W. Biochem. Biophys. Res. Commun. 1984; 120: 885-890Crossref PubMed Scopus (4244) Google Scholar). A causative role for Aऔ in AD progression has been accepted by many for some time (2Price D.L. Sisodia S.S. Annu. Rev. Neurosci. 1998; 21: 479-505Crossref PubMed Scopus (509) Google Scholar, 3Selkoe D.J. Nature. 1999; 399: A23-A31Crossref PubMed Scopus (1534) Google Scholar), and recent evidence from mouse models has underscored the importance of this peptide in the process of cognitive decline (4Chen G. Chen K.S. Knox J. Inglis J. Bernard A. Martin S.J. Justice A. McConlogue L. Games D. Freedman S.B. Morris R.G. Nature. 2000; 408: 975-979Crossref PubMed Scopus (9) Google Scholar, 5Janu

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m213303200

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 42

Metadata

Authors
Huse, J. T., Byant, D., Yang, Y., Pijak, D. S., D'Souza, I., Lah, J. J., Lee, V. M.-Y., Doms, R. W., & Cook, D. G.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2003-05
Volume
278
Issue
19
Pages
17141-17149
ISSN
0021-9258 (ISSN-L)
OpenAlex
W1990698453
Cited by
42
References
10
FWCI
1.99
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.